Anagrelide compared with hydroxyurea in WHO-classified essential thrombocythemia: the ANAHYDRET Study, a randomized controlled trial

2013318 citationsJournal Articlebronze Open Access

Authors

Key Points Noninferiority of anagrelide in comparison with hydroxyurea in WHO-essential thrombocythemia, a phase 3 trial

Good health and well-being

Published in: Blood

Volume 121, Issue 10, pp. 1720-1728

Field-Weighted Citation Impact: 18.09